Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- The Download: what’s next for AI, and stem-cell therapies
- 10 Mayo Clinic research advances in 2024, spanning stem cell therapy in space to growing mini-organs
- A pilot raced through the airport to surprise an old friend: the woman who saved his life
- 8 Trends to Watch in the Cell and Gene Therapy Market
- UNL researchers delving into which foods help slow aging of brain
- Australia’s Fast New 3D Bioprinter Can Mimic Human Tissues